Wolfgang Fischer
Chief Operating Officer at AFFIMED N.V.
Net worth: 573 704 $ as of 2024-03-30
Profile
Wolfgang Fischer is currently the Chief Operating Officer at Affimed NV and Affimed GmbH.
He previously worked as a Medical Director-Oncology at Novartis Pharma Schweiz AG.
He holds a doctorate degree from the Swiss Federal Institute of Technology and the University of Würzburg Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AFFIMED N.V.
0.72% | 2023-03-14 | 108,246 ( 0.72% ) | 573 704 $ | 2024-03-30 |
Wolfgang Fischer active positions
| Companies | Position | Start |
|---|---|---|
| AFFIMED N.V. | Chief Operating Officer | 2017-09-12 |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Chief Operating Officer | 2016-12-31 |
Former positions of Wolfgang Fischer
| Companies | Position | End |
|---|---|---|
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Corporate Officer/Principal | - |
Training of Wolfgang Fischer
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of Würzburg Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AFFIMED N.V. | Health Technology |
| Private companies | 2 |
|---|---|
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
- Stock Market
- Insiders
- Wolfgang Fischer
